May Measurement Month 2018: results of blood pressure screening from 41 countries

N.R. Poulter; C. Borghi; D. Burger; R.R. Castillo; A. Damasceno; S. Ito; A.P. Jose; R. Kruger; T. Morgan; P.M. Nilsson; M.P. Schlaich; A.E. Schutte; G. Stergiou; T. Unger; R.D. Wainford; T. Beaney

doi:10.1093/eurheartj/suaa013

May Measurement Month 2018: results of blood pressure screening from 41 countries

N.R. Poulter^*, C. Borghi, D. Burger, R.R. Castillo, A. Damasceno, S. Ito, A.P. Jose, R. Kruger, T. Morgan, P.M. Nilsson, M.P. Schlaich, A.E. Schutte, G. Stergiou, T. Unger, R.D. Wainford, T. Beaney^*

^*Corresponding author for this work

CARIM other

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	H1-H4
Number of pages	4
Journal	European Heart Journal Supplements
Volume	22
Issue number	H
DOIs	https://doi.org/10.1093/eurheartj/suaa013
Publication status	Published - 1 Aug 2020

Access to Document

10.1093/eurheartj/suaa013Licence: CC BY-NC

Cite this

Poulter, N. R., Borghi, C., Burger, D., Castillo, R. R., Damasceno, A., Ito, S., Jose, A. P., Kruger, R., Morgan, T., Nilsson, P. M., Schlaich, M. P., Schutte, A. E., Stergiou, G., Unger, T., Wainford, R. D., & Beaney, T. (2020). May Measurement Month 2018: results of blood pressure screening from 41 countries. European Heart Journal Supplements, 22(H), H1-H4. https://doi.org/10.1093/eurheartj/suaa013

@article{d00a0ad6e3034737b6581b36b990c081,

title = "May Measurement Month 2018: results of blood pressure screening from 41 countries",

author = "N.R. Poulter and C. Borghi and D. Burger and R.R. Castillo and A. Damasceno and S. Ito and A.P. Jose and R. Kruger and T. Morgan and P.M. Nilsson and M.P. Schlaich and A.E. Schutte and G. Stergiou and T. Unger and R.D. Wainford and T. Beaney",

note = "Funding Information: Conflict of interest: N.R.P. has received financial support from several pharmaceutical companies which manufacture BP-lowering agents, for consultancy fees (Servier), research projects and staff (Servier, Pfizer) and for arranging and speaking at educational meetings (AstraZeneca, LRI Therapharma, Napi, Servier, Sanofi, Eva Pharma, and Pfizer). He holds no stocks and shares in any such companies. R.R.C. is a member of advisory boards and speakers bureau of the Philippine affiliates of: Servier, Boehringer Ingelheim, Menarini, AstraZeneca, LRI-Therapharma, UAP Pharma, Sanofi, Trianon International; chairman of For God{\textquoteright}s Glory Foundation which receives medicine donations from various pharma companies for its medical missions. S.I. has received honorarium from Daiichi-Sankyo, Takeda, Boehringer Ingelheim, Kyowa-Kirin, Teijin Pharma. He holds no stocks. P.M.N. has lectured for several pharmaceutical companies (Astrazeneca Ltd, Boehringer-Ingelheim, Merck, Novo Nordisk A/S) but holds no stocks in such companies. M.P.S. is supported by an NHMRC Senior Research Fellowship and has received consulting fees, and/or travel and research support from Medtronic, Abbott, Novartis, Servier, Pfizer, and Boehringer-Ingelheim. A.E.S. received speaker honoraria from Omron Healthcare, Servier, Novartis, and Takeda, and serve on a research advisory board for Abbott Pharmaceuticals. G.S. has received research grants and consulting and lecturing fees from several pharmaceutical companies and manufactures of blood pressure measuring technologies, including AstraZeneca, Omron, Pfizer, Sanofi, and Servier. He has no stocks and shares in any such companies. The other authors declare no conflicts of interest.",

year = "2020",

month = aug,

day = "1",

doi = "10.1093/eurheartj/suaa013",

language = "English",

volume = "22",

pages = "H1--H4",

journal = "European Heart Journal Supplements",

issn = "1520-765X",

publisher = "Oxford University Press",

number = "H",

}

Poulter, NR, Borghi, C, Burger, D, Castillo, RR, Damasceno, A, Ito, S, Jose, AP, Kruger, R, Morgan, T, Nilsson, PM, Schlaich, MP, Schutte, AE, Stergiou, G, Unger, T, Wainford, RD & Beaney, T 2020, 'May Measurement Month 2018: results of blood pressure screening from 41 countries', European Heart Journal Supplements, vol. 22, no. H, pp. H1-H4. https://doi.org/10.1093/eurheartj/suaa013

TY - JOUR

T1 - May Measurement Month 2018: results of blood pressure screening from 41 countries

AU - Poulter, N.R.

AU - Borghi, C.

AU - Burger, D.

AU - Castillo, R.R.

AU - Damasceno, A.

AU - Ito, S.

AU - Jose, A.P.

AU - Kruger, R.

AU - Morgan, T.

AU - Nilsson, P.M.

AU - Schlaich, M.P.

AU - Schutte, A.E.

AU - Stergiou, G.

AU - Unger, T.

AU - Wainford, R.D.

AU - Beaney, T.

N1 - Funding Information: Conflict of interest: N.R.P. has received financial support from several pharmaceutical companies which manufacture BP-lowering agents, for consultancy fees (Servier), research projects and staff (Servier, Pfizer) and for arranging and speaking at educational meetings (AstraZeneca, LRI Therapharma, Napi, Servier, Sanofi, Eva Pharma, and Pfizer). He holds no stocks and shares in any such companies. R.R.C. is a member of advisory boards and speakers bureau of the Philippine affiliates of: Servier, Boehringer Ingelheim, Menarini, AstraZeneca, LRI-Therapharma, UAP Pharma, Sanofi, Trianon International; chairman of For God’s Glory Foundation which receives medicine donations from various pharma companies for its medical missions. S.I. has received honorarium from Daiichi-Sankyo, Takeda, Boehringer Ingelheim, Kyowa-Kirin, Teijin Pharma. He holds no stocks. P.M.N. has lectured for several pharmaceutical companies (Astrazeneca Ltd, Boehringer-Ingelheim, Merck, Novo Nordisk A/S) but holds no stocks in such companies. M.P.S. is supported by an NHMRC Senior Research Fellowship and has received consulting fees, and/or travel and research support from Medtronic, Abbott, Novartis, Servier, Pfizer, and Boehringer-Ingelheim. A.E.S. received speaker honoraria from Omron Healthcare, Servier, Novartis, and Takeda, and serve on a research advisory board for Abbott Pharmaceuticals. G.S. has received research grants and consulting and lecturing fees from several pharmaceutical companies and manufactures of blood pressure measuring technologies, including AstraZeneca, Omron, Pfizer, Sanofi, and Servier. He has no stocks and shares in any such companies. The other authors declare no conflicts of interest.

PY - 2020/8/1

Y1 - 2020/8/1

U2 - 10.1093/eurheartj/suaa013

DO - 10.1093/eurheartj/suaa013

M3 - Article

C2 - 32884454

SN - 1520-765X

VL - 22

SP - H1-H4

JO - European Heart Journal Supplements

JF - European Heart Journal Supplements

IS - H

ER -